Repaglinide
NDC 57237-158, Repaglinide, tablet, from Rising Pharma Holdings, Inc..
- Product NDC
- 57237-158
- Status
- Listed
- Labeler
- Rising Pharma Holdings, Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA203820
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/57237-158 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- REPAGLINIDE1 mg/1
Pharmacologic classes
Glinide [EPC]; Potassium Channel Antagonists [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 57237-158-01 | 57237015801 | 100 TABLET in 1 BOTTLE (57237-158-01) |
| 57237-158-05 | 57237015805 | 500 TABLET in 1 BOTTLE (57237-158-05) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/d7673e22-0dbb-4395-ad60-943d249203a1NADAC price for package 57237015801
GET /v1/drugs/nadac/57237015801
Use it
Look up 57237-158 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/57237-158 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 57237-158. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.